Evidence map›Paper›PMID 34784345›Full record

ArticlePLoS biology2021

Systematic exploration of Escherichia coli phage-host interactions with the BASEL phage collection.

Enea Maffei, Aisylu Shaidullina, Marco Burkolter, Yannik Heyer, Fabienne Estermann, Valentin Druelle, Patrick Sauer, Luc Willi, Sarah Michaelis, Hubert Hilbi and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed, 2 pooled it
27.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed, 2 syntheses or guidelines pooled it, 286 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Characterization of defensome genes and mobile genetic Elements in different types of pasture soil agroecosystems from the Brazilian Amazon.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Enea MaffeiBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-0751-9572
Aisylu ShaidullinaBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-2691-3006
Marco BurkolterBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-0312-3511
Yannik HeyerBiozentrum, University of Basel, Basel, Switzerland.
Fabienne EstermannBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-9629-4386
Valentin DruelleBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-2554-4982
Patrick SauerBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0002-9378-2851
Luc WilliBiozentrum, University of Basel, Basel, Switzerland.
Sarah MichaelisInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland.
Hubert HilbiInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-5462-9301
David S ThalerBiozentrum, University of Basel, Basel, Switzerland.
Alexander HarmsBiozentrum, University of Basel, Basel, Switzerland.ORCID 0000-0003-2106-1286
University of Basel · CHUniversity of Zurich · CH

Funding

TimeAware Data Acquisition,RealTime Processing for fMRIR33EB001484 · NIBIB · UNIVERSITY OF IOWA · PI GRABOWSKI, THOMAS J. · 2003 to 2005
$981k
NIBIB NIH HHS R33 EB001484
6 · The paper itself

Abstract

Bacteriophages, the viruses infecting bacteria, hold great potential for the treatment of multidrug-resistant bacterial infections and other applications due to their unparalleled diversity and recent breakthroughs in their genetic engineering. However, fundamental knowledge of the molecular mechanisms underlying phage-host interactions is mostly confined to a few traditional model systems and did not keep pace with the recent massive expansion of the field. The true potential of molecular biology encoded by these viruses has therefore remained largely untapped, and phages for therapy or other applications are often still selected empirically. We therefore sought to promote a systematic exploration of phage-host interactions by composing a well-assorted library of 68 newly isolated phages infecting the model organism Escherichia coli that we share with the community as the BASEL (BActeriophage SElection for your Laboratory) collection. This collection is largely representative of natural E. coli phage diversity and was intensively characterized phenotypically and genomically alongside 10 well-studied traditional model phages. We experimentally determined essential host receptors of all phages, quantified their sensitivity to 11 defense systems across different layers of bacterial immunity, and matched these results to the phages' host range across a panel of pathogenic enterobacterial strains. Clear patterns in the distribution of phage phenotypes and genomic features highlighted systematic differences in the potency of different immunity systems and suggested the molecular basis of receptor specificity in several phage groups. Our results also indicate strong trade-offs between fitness traits like broad host recognition and resistance to bacterial immunity that might drive the divergent adaptation of different phage groups to specific ecological niches. We envision that the BASEL collection will inspire future work exploring the biology of bacteriophages and their hosts by facilitating the discovery of underlying molecular mechanisms as the basis for an effective translation into biotechnology or therapeutic applications.

Indexed as

ColiphagesEscherichia coliHost-Pathogen InteractionsHost SpecificityImmunityPhenotypePhylogenyPolysaccharidesReceptors, Cell SurfaceSalmonellaViral ProteinsPolysaccharidesReceptors, Cell SurfaceViral Proteins

Identifiers

PMID34784345
PMCPMC8594841
OpenAlexW3211357821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.